Association of Pre-Hospital Antiplatelet Therapy with Survival in Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis

CONCLUSIONS: In the largest observational study to date of pre-hospital antiplatelet therapy in patients with COVID-19, there was an association with significantly lower in-hospital mortality. Randomized controlled trials in diverse patient populations with high rates of baseline comorbidities are needed to determine the ultimate utility of antiplatelet therapy in COVID-19.PMID:34455688 | DOI:10.1111/jth.15517

Source: Thrombosis and Haemostasis - August 29, 2021 Category: Hematology Authors: Jonathan H Chow Ying Yin David P Yamane Danielle Davison Ryan Keneally Katrina Hawkins Gage Parr Mustafa Al-Mashat Jeffery S Berger Reamer L Bushardt Michael A Mazzeffi Stuart J Nelson Source Type: research